HN-1

General Information


DRACP ID  DRACP05199

Peptide Name   HN-1

Sequence  TSPLNIHNGQKL

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Not available

Disulfide/Other Bond  Not available

N-terminal Modification  fluorescein/ FITC/texas red

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C57H96N18O18

Absent amino acids  ACDEFMRVWY

Common amino acids  LN

Mass  151789

Pl  9.7

Basic residues  2

Acidic residues  0

Hydrophobic residues  3

Net charge  2

Boman Index  -1930

Hydrophobicity  -75

Aliphatic Index  97.5

Half Life 
  Mammalian: 1.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 11118031

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN111225679A

Patent Title  Novel Peptide-Based Cancer Imaging Agents

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  1505

DRACP is developed by Dr.Zheng's team.